Following footsteps of chart-topping Chinese counterparts, Alphamab Oncology files IPO at HKEX
Less than two months after raising $60 million — its second venture round in a decade — Alphamab is making the hop for the public markets. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
